116 related articles for article (PubMed ID: 31538281)
1. Prevalence of potential drug-drug interactions in outpatients on treatment with parenteral antineoplastic drugs.
Castro-Manzanares M; do Pazo-Oubiña F; Rodríguez-Rincón RM
Int J Clin Pharm; 2019 Dec; 41(6):1429-1433. PubMed ID: 31538281
[TBL] [Abstract][Full Text] [Related]
2. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
3. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
5. Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice.
Escudero-Vilaplana V; Collado-Borrell R; Hoyo-Muñoz A; Gimenez-Manzorro A; Calles A; Osorio S; Herranz-Alonso A; Sanjurjo-Sáez M
Expert Opin Drug Saf; 2020 Aug; 19(8):1041-1048. PubMed ID: 32529857
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of potential drug-drug interactions in outpatients of a general hospital in China: a retrospective investigation.
Ren W; Liu Y; Zhang J; Fang Z; Fang H; Gong Y; Lv X
Int J Clin Pharm; 2020 Aug; 42(4):1190-1196. PubMed ID: 32488437
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
Goh I; Lai O; Chew L
Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
[TBL] [Abstract][Full Text] [Related]
9. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
10. Observational study of drug-drug interactions in oncological inpatients.
Díaz-Carrasco MS; Almanchel-Rivadeneyra M; Tomás-Luiz A; Pelegrín-Montesinos S; Ramírez-Roig C; Fernández-Ávila JJ
Farm Hosp; 2018 Jan; 42(1):10-15. PubMed ID: 29306307
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
Su BB; Ma JX; Song W; Yuan J; Dong XY; Wan J
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1983-1987. PubMed ID: 32629601
[No Abstract] [Full Text] [Related]
13. Prevalence study on potential drug-drug interaction in cancer patients in Piacenza hospital's Onco-Haematology department.
Vecchia S; Orlandi E; Confalonieri C; Damonti E; Riva A; Sartori A; Cavanna L
J Oncol Pharm Pract; 2018 Oct; 24(7):490-493. PubMed ID: 28714379
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
15. Potential drug interactions and duplicate prescriptions among cancer patients.
Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
Nightingale G; Hajjar E; Swartz K; Andrel-Sendecki J; Chapman A
J Clin Oncol; 2015 May; 33(13):1453-9. PubMed ID: 25800766
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pharmacist Intervention on a Population in Taiwan with High Healthcare Utilization and Excessive Polypharmacy.
Wang TC; Trezise D; Ku PJ; Lu HL; Hsu KC; Hsu PC
Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31234455
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of drug interactions in patients treated for a lung or digestive cancer].
Ghysel V; Tresch E; Marliot G; Nicot R; Lambert M; Carbonnelle G; Lartigau E; Lefebvre G
Bull Cancer; 2020 Nov; 107(11):1108-1117. PubMed ID: 33012503
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prescribing patterns, adverse effects, and drug interactions of oral chemotherapy agents in an outpatient cancer center.
Solomon JM; Ajewole VB; Schneider AM; Sharma M; Bernicker EH
J Oncol Pharm Pract; 2019 Oct; 25(7):1564-1569. PubMed ID: 30170514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
